An automated computed tomography score for the cystic fibrosis lung

Eur Radiol. 2018 Dec;28(12):5111-5120. doi: 10.1007/s00330-018-5516-x. Epub 2018 Jun 4.

Abstract

Objectives: To develop an automated density-based computed tomography (CT) score evaluating high-attenuating lung structural abnormalities in patients with cystic fibrosis (CF).

Methods: Seventy adult CF patients were evaluated. The development cohort comprised 17 patients treated with ivacaftor, with 45 pre-therapeutic and follow-up chest CT scans. Another cohort of 53 patients not treated with ivacaftor was used for validation. CT-density scores were calculated using fixed and adapted thresholds based on histogram characteristics, such as the mode and standard deviation. Visual CF-CT score was also calculated. Correlations between the CT scores and forced expiratory volume in 1 s (FEV1% pred), and between their changes over time were assessed.

Results: On cross-sectional evaluation, the correlation coefficients between FEV1%pred and the automated scores were slightly lower to that of the visual score in the development and validation cohorts (R = up to -0.68 and -0.61, versus R = -0.72 and R = -0.64, respectively). Conversely, the correlation to FEV1%pred tended to be higher for automated scores (R = up to -0.61) than for visual score (R = -0.49) on longitudinal follow-up. Automated scores based on Mode + 3 SD and Mode +300 HU showed the highest cross-sectional (R = -0.59 to -0.68) and longitudinal (R = -0.51 to -0.61) correlation coefficients to FEV1%pred.

Conclusions: The developed CT-density score reliably quantifies high-attenuating lung structural abnormalities in CF.

Key points: • Automated CT score shows moderate to good cross-sectional correlations with FEV 1 %pred . • CT score has potential to be integrated into the standard reporting workflow.

Keywords: Cystic fibrosis; Forced expiratory volume; Image processing computer-assisted; Scoring methods; Tomography spiral computed.

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Aminophenols / pharmacology
  • Aminophenols / therapeutic use
  • Chloride Channel Agonists / pharmacology
  • Chloride Channel Agonists / therapeutic use
  • Cross-Sectional Studies
  • Cystic Fibrosis / diagnostic imaging*
  • Cystic Fibrosis / drug therapy
  • Cystic Fibrosis / physiopathology
  • Female
  • Forced Expiratory Volume / drug effects
  • Humans
  • Lung / diagnostic imaging*
  • Male
  • Observer Variation
  • Quinolones / pharmacology
  • Quinolones / therapeutic use
  • Reproducibility of Results
  • Respiratory Function Tests
  • Retrospective Studies
  • Tomography, Spiral Computed / methods
  • Young Adult

Substances

  • Aminophenols
  • Chloride Channel Agonists
  • Quinolones
  • ivacaftor